MedCu is proud to be the first company to gain FDA and CE clearances for marketing copper-based wound dressings.Leveraging copper's potent antibacterial properties, MedCu provides a unique proposition to address acute, critical and chronic wounds. The copper-based wound dressings follow the successful commercialization of copper compounds impregnation into various fabrics and polymers after 15 years of research and are protected by 30 patents worldwide.